Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Melatonin and its atheroprotective effects: a review.

Favero G, Rodella LF, Reiter RJ, Rezzani R.

Mol Cell Endocrinol. 2014 Feb 15;382(2):926-37. doi: 10.1016/j.mce.2013.11.016. Epub 2013 Nov 28. Review.

PMID:
24291636
2.

Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin.

Rezzani R, Favero G, Stacchiotti A, Rodella LF.

Life Sci. 2013 May 20;92(17-19):875-82. doi: 10.1016/j.lfs.2012.11.011. Epub 2012 Nov 27.

PMID:
23201430
3.

Anti-atherosclerotic molecules targeting oxidative stress and inflammation.

Adameova A, Xu YJ, Duhamel TA, Tappia PS, Shan L, Dhalla NS.

Curr Pharm Des. 2009;15(27):3094-107. Review.

PMID:
19754384
4.

[Melatonin in the treatment of atherosclerosis].

Broncel M, Koziróg-Kołacińska M, Chojnowska-Jezierska J.

Pol Merkur Lekarski. 2007 Aug;23(134):124-7. Review. Polish.

PMID:
18044343
5.

Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state.

Korkmaz A, Ma S, Topal T, Rosales-Corral S, Tan DX, Reiter RJ.

Mol Cell Endocrinol. 2012 Feb 26;349(2):128-37. doi: 10.1016/j.mce.2011.10.013. Epub 2011 Nov 4. Review.

PMID:
22079284
6.

Melatonin: a pleiotropic molecule regulating inflammation.

Radogna F, Diederich M, Ghibelli L.

Biochem Pharmacol. 2010 Dec 15;80(12):1844-52. doi: 10.1016/j.bcp.2010.07.041. Epub 2010 Aug 7. Review.

PMID:
20696138
7.

Cardiovascular diseases: protective effects of melatonin.

Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R.

J Pineal Res. 2008 Jan;44(1):16-25. Review.

PMID:
18078444
8.

Actions of melatonin in the reduction of oxidative stress. A review.

Reiter RJ, Tan DX, Osuna C, Gitto E.

J Biomed Sci. 2000 Nov-Dec;7(6):444-58. Review.

PMID:
11060493
9.

Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.

Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M.

Hypertens Res. 2006 Jun;29(6):457-66.

PMID:
16940709
10.

Can carotenoids attenuate vascular aging?

Wolak T, Paran E.

Vascul Pharmacol. 2013 Sep-Oct;59(3-4):63-6. doi: 10.1016/j.vph.2013.07.006. Epub 2013 Jul 29. Review.

PMID:
23906847
11.

Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.

Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M.

Curr Med Chem. 2009;16(35):4654-67. Review.

PMID:
19903143
12.

IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.

Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. Epub 2007 Oct 4.

13.
14.

Melatonin: action as antioxidant and potential applications in human disease and aging.

Bonnefont-Rousselot D, Collin F.

Toxicology. 2010 Nov 28;278(1):55-67. doi: 10.1016/j.tox.2010.04.008. Epub 2010 Apr 24. Review.

PMID:
20417677
15.

Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Hu S, Yin S, Jiang X, Huang D, Shen G.

Eur J Pharmacol. 2009 Aug 15;616(1-3):287-92. doi: 10.1016/j.ejphar.2009.06.044. Epub 2009 Jul 2.

PMID:
19576882
16.

Melatonin: an ancient molecule that makes oxygen metabolically tolerable.

Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX, Reiter RJ.

J Pineal Res. 2015 Nov;59(4):403-19. doi: 10.1111/jpi.12267. Epub 2015 Sep 11. Review.

PMID:
26272235
17.

Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.

Escames G, Acuña-Castroviejo D, López LC, Tan DX, Maldonado MD, Sánchez-Hidalgo M, León J, Reiter RJ.

J Pharm Pharmacol. 2006 Sep;58(9):1153-65. Review.

PMID:
16945173
18.

Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis.

Leonarduzzi G, Gamba P, Gargiulo S, Biasi F, Poli G.

Free Radic Biol Med. 2012 Jan 1;52(1):19-34. doi: 10.1016/j.freeradbiomed.2011.09.031. Epub 2011 Oct 2. Review.

19.

Gene regulation by melatonin linked to epigenetic phenomena.

Korkmaz A, Rosales-Corral S, Reiter RJ.

Gene. 2012 Jul 15;503(1):1-11. doi: 10.1016/j.gene.2012.04.040. Epub 2012 May 1. Review.

PMID:
22569208
20.

Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors.

Choi SI, Dadakhujaev S, Ryu H, Im Kim T, Kim EK.

J Pineal Res. 2011 Aug;51(1):94-103. doi: 10.1111/j.1600-079X.2011.00866.x. Epub 2011 Mar 11.

PMID:
21392093

Supplemental Content

Support Center